Liquidia LQDA
NASDAQ LQDA
$68.68 +1.00 (+1.47%)
As of: Sep 9, 2026 · 2:36 PM EDT

Liquidia (LQDA) Non Operating Income (2020 - 2026)

Liquidia (LQDA) posted Non Operating Income of -$3.8 million for Q2 2026, up 19.1% on a QoQ basis from -$4.7 million in Q1 2026, and up 6.23% year-over-year from -$3.6 million in Q2 2025.

Analysis

Liquidia (LQDA) Non Operating Income (2020 - 2026) Analysis & Trends

Liquidia has reported Non Operating Income for 7 years, with the latest figure at -$3.8 million in Q2 2026.

  • On a quarterly basis, Non Operating Income rose 6.23% year-over-year to -$3.8 million in Q2 2026; TTM through Jun 2026 was -$19.1 million, a 69.4% decrease from a year earlier, with the FY2025 full-year figure at -$17.5 million, down 150.79% from the prior year.
  • Non Operating Income was -$3.8 million for Q2 2026 at Liquidia, up from -$4.7 million in the prior quarter.
  • The five-year high for Non Operating Income was -$36000.0 in Q4 2022, with the low at -$5.3 million in Q3 2025.
  • Average Non Operating Income over 5 years is -$2.2 million, with a median of -$1.7 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2023: Non Operating Income jumped 82.09% in 2022, then tumbled 2716.67% in 2023.
  • Over 5 years, Non Operating Income stood at -$36000.0 in 2022, then sank by 2716.67% to -$1.0 million in 2023, then tumbled by 136.98% to -$2.4 million in 2024, then slumped by 117.73% to -$5.2 million in 2025, then rose by 26.99% to -$3.8 million in 2026.
  • The last three Non Operating Income figures came in at -$3.8 million (Q2 2026), -$4.7 million (Q1 2026), and -$5.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 645.95 Bn 625.20 Bn 17.26 Bn -
2 AbbVie 441.39 Bn 434.82 Bn 12.70 Bn -
3 Merck 366.72 Bn 359.58 Bn 12.21 Bn -
4 Novartis Ag 266.68 Bn 258.99 Bn 11.24 Bn -
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn -
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -
7 Revolution Medicines 44.08 Bn 44.08 Bn - -139.24 Mn
8 Incyte 25.50 Bn 20.96 Bn 1.57 Bn -
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn 41.90 Mn
10 Liquidia 6.10 Bn 5.81 Bn 160.92 Mn -3.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.82 Mn
Mar 31, 2026 -4.72 Mn
Dec 31, 2025 -5.23 Mn
Sep 30, 2025 -5.30 Mn
Jun 30, 2025 -4.07 Mn
Mar 31, 2025 -2.94 Mn
Dec 31, 2024 -2.40 Mn
Sep 30, 2024 -1.84 Mn
Jun 30, 2024 -1.47 Mn
Mar 31, 2024 -1.28 Mn
Dec 31, 2023 -1.01 Mn
Sep 30, 2023 -899,000.00
Jun 30, 2023 -692,000.00
Mar 31, 2023 -2.51 Mn
Dec 31, 2022 -36,000.00
Sep 30, 2022 -261,000.00
Jun 30, 2022 -477,000.00
Mar 31, 2022 -1.47 Mn
Dec 31, 2021 -201,000.00
Sep 30, 2021 -201,000.00